We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Medtronic/Covidien Deal Mentioned In Hearing on Corporate Inversions
Medtronic/Covidien Deal Mentioned In Hearing on Corporate Inversions
Medtronic’s pending $45 billion acquisition of Covidien was in the congressional spotlight after a recent call by U.S. Treasury Secretary Jack Lew to pass bills limiting corporate inversion deals.